Výsledky vyhledávání

Akademický článek

Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis.

Autor: Dignass A; Department of Gastroenterology, Hepatology, Oncology and Pneumology, Markus Hospital, Frankfurt, Germany., Ainsworth C; OPEN Health HEOR & Market Access, Manchester, UK., Hartz S; Eli Lilly and Company, Indianapolis, IN, USA. hartz_susanne@lilly.com.; Eli Lilly and Company Limited, 8 Arlington Square West, Downshire Way, Bracknell, RG12 1PU, UK. hartz_susanne@lilly.com., Dunnewind N; OPEN Health HEOR & Market Access, Rotterdam, Netherlands., Redondo I; Eli Lilly and Company, Indianapolis, IN, USA., Sapin C; Eli Lilly and Company, Indianapolis, IN, USA., Kroep S; OPEN Health HEOR & Market Access, Rotterdam, Netherlands., Halfpenny N; OPEN Health HEOR & Market Access, Rotterdam, Netherlands., Arcà E; OPEN Health HEOR & Market Access, Rotterdam, Netherlands., Hoque S; Barts Health NHS Trust, London, UK.

Publikováno v: Advances in therapy [Adv Ther] 2024 Dec; Vol. 41 (12), pp. 4446-4462. Date of Electronic Publication: 2024 Oct 15.

Zobrazit plný text záznamu

Akademický článek

Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis.

Autor: McGonagle D; Leeds Institute of Rheumatic and Musculoskeletal Medicine, NIHR Leeds Biomedical Research Centre, University of Leeds, Leeds, UK., Kavanaugh A; Department of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, CA, USA., McInnes IB; College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Kristensen LE; The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark., Merola JF; Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern, Dallas, TX, USA., Strober B; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.; Central Connecticut Dermatology, Cromwell, CT, USA., Bolce R; Eli Lilly and Company, Indianapolis, IN, USA., Lisse J; Eli Lilly and Company, Indianapolis, IN, USA., Pustizzi J; Eli Lilly and Company, Indianapolis, IN, USA., Sapin C; Eli Lilly and Company, Indianapolis, IN, USA., Ritchlin C; Department of Medicine, Division of Allergy, Immunology, Rheumatology, University of Rochester Medical Center, Rochester, NY, USA.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Nov 01; Vol. 63 (11), pp. 3115-3123.

Zobrazit plný text záznamu

Compte-rendu : SAPIN (C.), SIMON-HIERNARD (D.) éd. — Le stuc : Visage oublié de l'art médiéval, catalogue d'exposition, Musée Sainte-Croix de Poitiers 16 septembre 2004 – 16 janvier 2005, Poitiers, Somogny éditions d'art/Musées de Poitiers, 2004

Autor: Hartmann-Virnich, Andreas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______166::73930cffb3f0a1b5f14233206638c7d2
https://shs.hal.science/halshs-00521814

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

Autor: Aigbogun MS, Liu S, Kamat SA, Sapin C, Duhig AM, Citrome L

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 443-456 (2018)

Myrlene S Aigbogun,1 Sizhu Liu,2 Siddhesh A Kamat,1 Christophe Sapin,3 Amy M Duhig,2 Leslie Citrome4 1Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization, Inc, Princeton, NJ, USA; 2Global Health Economics a

Externí odkaz: https://doaj.org/article/d7e97eda1ddf448eab4b5b3d3057fe58

Zobrazit plný text záznamu

Akademický článek

Shortening the VSP-A: Preliminary Development of the VSP-A12, a 12-Item Short-Form

Autor: Sapin, C., Auquier, P.

Publikováno v: Quality of Life Research, 2004 Feb 01. 13(1), 235-241.

Externí odkaz: https://www.jstor.org/stable/4038155

Zobrazit plný text záznamu

Akademický článek

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.

Autor: Travis S; Kennedy Institute and Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom., Potts Bleakman A; Eli Lilly and Company, Indianapolis, IN, USA., Dubinsky MC; Susan and Leonard Feinstein IBD Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Schreiber S; Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Germany., Panaccione R; Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada., Hibi T; Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan., Hunter Gibble T; Eli Lilly and Company, Indianapolis, IN, USA., Kayhan C; Eli Lilly and Company, Indianapolis, IN, USA., Atkinson C; Adelphi Real World, Bollington, United Kingdom., Sapin C; Eli Lilly and Company, Indianapolis, IN, USA., Flynn EJ; Eli Lilly and Company, Indianapolis, IN, USA., Rubin DT; University of Chicago Medicine Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.

Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Jun 03; Vol. 30 (6), pp. 939-949.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání